We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Assertio Holdings Inc | NASDAQ:ASRT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0298 | 2.95% | 1.0398 | 1.02 | 1.05 | 1.04 | 0.9901 | 1.01 | 601,274 | 23:26:38 |
Participants can access the live webcast from the Investor Relations section of Assertio's website at http://investor.assertiotx.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.
Audio Conference Call:
U.S. Dial-in Number: | 1-877-550-3745 |
International Dial-in Number: | 1-281-973-6277 |
Conference ID: | 7769879 |
An archived webcast replay will be available on the Company's website accessed by visiting http://investor.assertiotx.com.
About Assertio Therapeutics, Inc.Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. To learn more about Assertio, visit www.assertiotx.com.
Investor and Media Contact:John B. Thomas Senior Vice President, Investor Relations and Corporate Communications jthomas@assertiotx.com
1 Year Assertio Chart |
1 Month Assertio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions